Clinical Trial Update: Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating post-thrombectomy intra-arterial tenecteplase for acute ischemic stroke due to non-retrievable thrombus and no-re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrovascular Disease
• Stroke

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: University of Melbourne | Conditions: Ischemic Stroke, Acute, Cerebrovascular Disorders | Phase 2, Phase 3 | Status: RECRUITING